APA

Heskamp S., Boerman O. C., Molkenboer-Kuenen J. D. M., Sweep F. C. G. J., Geurts-Moespot A., Engelhardt M. S., van der Graaf W. T. A., Oyen W. J. G. & van Laarhoven H. W. M. (20150714). Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression. : Molecular pharmaceutics.

Chicago

Heskamp Sandra, Boerman Otto C, Molkenboer-Kuenen Janneke D M, Sweep Fred C G J, Geurts-Moespot Anneke, Engelhardt Mallory S, van der Graaf Winette T A, Oyen Wim J G and van Laarhoven Hanneke W M. 20150714. Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression. : Molecular pharmaceutics.

Harvard

Heskamp S., Boerman O. C., Molkenboer-Kuenen J. D. M., Sweep F. C. G. J., Geurts-Moespot A., Engelhardt M. S., van der Graaf W. T. A., Oyen W. J. G. and van Laarhoven H. W. M. (20150714). Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression. : Molecular pharmaceutics.

MLA

Heskamp Sandra, Boerman Otto C, Molkenboer-Kuenen Janneke D M, Sweep Fred C G J, Geurts-Moespot Anneke, Engelhardt Mallory S, van der Graaf Winette T A, Oyen Wim J G and van Laarhoven Hanneke W M. Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression. : Molecular pharmaceutics. 20150714.